Cargando…

Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma

BACKGROUND: Ferroptosis is a new type of iron- and reactive oxygen species-dependent cell death, studies on ferroptosis-related long noncoding RNAs (FerLncRNAs) in clear cell renal cell carcinoma (ccRCC) are limited. The purpose of this study was to investigate the potential prognostic value of FerL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Lincheng, Shi, Yaxing, Liu, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2022
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774008/ https://www.ncbi.nlm.nih.gov/pubmed/36570012 http://dx.doi.org/10.7717/peerj.14506

Ejemplares similares

A robust immune-related lncRNA signature for the prognosis of human colorectal cancer
por: Zhu, Gongmin, et al.
Publicado: (2022)

Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma
por: Ma, Wei, et al.
Publicado: (2021)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer
por: Zhang, Yang, et al.
Publicado: (2022)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

A seven-lncRNA signature for predicting Ewing’s sarcoma
por: Chen, Zhihui, et al.
Publicado: (2021)

Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer
por: Li, Ruowen, et al.
Publicado: (2023)

Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma
por: Ren, He, et al.
Publicado: (2020)

Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Fang, Chongkai, et al.
Publicado: (2022)

Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma
por: Cheng, Fajuan, et al.
Publicado: (2021)

A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma
por: Ma, Sheng, et al.
Publicado: (2023)

Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients
por: Cai, Jingjing, et al.
Publicado: (2021)

Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma
por: Jiang, Mingzhe, et al.
Publicado: (2020)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma
por: Lai, Jiayi, et al.
Publicado: (2023)

Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma
por: Zhu, Jiahao, et al.
Publicado: (2022)

Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients
por: Hu, Yan, et al.
Publicado: (2021)

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature
por: Liu, Gang, et al.
Publicado: (2023)

Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma
por: Ma, Linkun, et al.
Publicado: (2019)

Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune‐related lncRNA
por: Shen, Shuang, et al.
Publicado: (2021)

Computational detection of a genome instability‐derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma
por: Guo, Chen‐Rui, et al.
Publicado: (2021)

Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma
por: Liu, Peijun, et al.
Publicado: (2023)

lncRNA TMEM51-AS1 and RUSC1-AS1 function as ceRNAs for induction of laryngeal squamous cell carcinoma and prediction of prognosis
por: Hui, Lian, et al.
Publicado: (2019)

Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma
por: Zhong, Tingting, et al.
Publicado: (2022)

Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients
por: Zhang, Zhiqiao, et al.
Publicado: (2018)

Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma
por: Li, Chengyun, et al.
Publicado: (2020)

Construction of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in thymic epithelial tumors
por: Su, Yongchao, et al.
Publicado: (2022)

Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma
por: Mao, Deli, et al.
Publicado: (2020)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer
por: Li, Zheng, et al.
Publicado: (2021)

High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment
por: Tian, Yixin, et al.
Publicado: (2020)

Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer
por: Wang, Minghui, et al.
Publicado: (2021)

A robust signature of immune‐related long non‐coding RNA to predict the prognosis of bladder cancer
por: Lai, Cong, et al.
Publicado: (2021)

Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database
por: Wu, Wenjuan, et al.
Publicado: (2019)

Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
por: Fu, Yang, et al.
Publicado: (2019)

Development and validation of a personalized classifier to predict the prognosis and response to immunotherapy in glioma based on glycolysis and the tumor microenvironment
por: Fan, Pengfei, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Comprehensive analysis of lncRNA-associated competing endogenous RNA network in tongue squamous cell carcinoma
por: Zhang, Shusen, et al.
Publicado: (2019)

Bioinformatics identification and integrative analysis of ferroptosis-related key lncRNAs in patients with osteoarthritis
por: Yang, Tengyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j4p98tvd5sslkodap11r3u3kc5